Source comparison
CJC-1295 vs HGH Therapy: Cost, Legality, and Practical Comparison
Mechanism of Action GHRH analog. Stimulates pituitary GH secretion in pulsatile patterns Exogenous bioidentical GH. Replaces endogenous secretion CJC-1295 preserves natural rhythm; HGH bypasses it entirely Dosing Frequency 1–2 subcutaneous injections per week
This comparison does not assign a generated winner or score.
- Mechanism of Action
- GHRH analog. Stimulates pituitary GH secretion in pulsatile patterns
- Exogenous bioidentical GH. Replaces endogenous secretion
- CJC-1295 preserves natural rhythm; HGH bypasses it entirely
- Dosing Frequency
- 1–2 subcutaneous injections per week (typical: 2 mg weekly)
- Daily subcutaneous injections (typical: 2–4 IU/day, 0.67–1.33 mg)
- CJC-1295 requires far fewer injections
- IGF-1 Elevation
- 20–40% above baseline (pulsatile)
- 60–120% above baseline (sustained)
- HGH produces higher peak IGF-1 but risks receptor desensitisation
- Endogenous GH Suppression
- Minimal. Works through natural feedback loops
- 60–85% suppression of natural GH pulses within one week
- CJC-1295 doesn't shut down your pituitary
- Cost (Monthly)
- $150–$350 for research-grade peptides from 503B-registered facilities like Real Peptides
- $600–$1,200 for pharmaceutical-grade rhGH (brand-dependent)
- CJC-1295 costs 50–75% less per month
- Legal Status
- Unscheduled research peptide. Legal to possess for research; not FDA-approved for human use
- Prescription-only Schedule III controlled substance (anabolic steroid classification under federal law)
- HGH requires medical necessity diagnosis; CJC-1295 exists in regulatory grey area
- Side Effect Profile
- Mild: injection site reactions, transient water retention, rare flushing
- Moderate to severe: carpal tunnel syndrome, joint pain, insulin resistance, gynecomastia risk at supraphysiological doses
- CJC-1295 generally better tolerated at standard research doses
- The cost differential compounds over time. A 12-month CJC-1295 protocol runs $1,800–$4,200; pharmaceutical HGH for the same period costs $7,200–$14,400. That's before factoring in required lab work. HGH therapy typically requires quarterly IGF-1, fasting glucose, and HbA1c monitoring due to metabolic side effects, adding $400–$800 annually.